Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Vizgen, Inc.

Vizgen to Present Spatial Multi-Omics Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
From Vizgen, Inc.
Via Business Wire
Study Published in Nature Neuroscience Spotlights the Use of Vizgen’s MERSCOPE® Platform to Uncover New Insights about Aging
From Vizgen, Inc.
Via Business Wire
Vizgen Expands Portfolio of Multi-Omics Tools for Discovery and Translational Research with MERFISH 2.0 Chemistry and Enhanced OmniVUE Panels with ADC Biomarkers
From Vizgen, Inc.
Via Business Wire
Vizgen Announces End of Litigation with 10x Genomics and Harvard University
From Vizgen, Inc.
Via Business Wire
Vizgen Announces New Appointments to Board of Directors and Executive Leadership Team
From Vizgen, Inc.
Via Business Wire
Vizgen Launches Certified Service Provider (CSP) Program, Expanding Access to Single-Cell Spatial Genomics Technology
From Vizgen, Inc.
Via Business Wire
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms and Drive Innovation in Spatial Multi-Omics
From Vizgen, Inc.
Via Business Wire
Vizgen Announces First Worldwide Shipments of MERSCOPE Ultra™, Ushering in a New Frontier in Spatial Genomics
From Vizgen, Inc.
Via Business Wire
Vizgen Issued a New US Patent for Its MERFISH Technology
From Vizgen, Inc.
Via Business Wire
Vizgen Expands Single-Cell Spatial Transcriptomics Offering with Introduction of MERSCOPE® Ultra Platform and MERFISH 2.0 Chemistry at AACR 2024
From Vizgen, Inc.
Via Business Wire
Vizgen Announces Denial of 10x Genomics’ Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted Against 10x’s Xenium Platform
From Vizgen, Inc.
Via Business Wire
With Capital Raise, Vizgen Commits to Its Long-term Success and Defense Against Baseless Anti-Competitive Legal Actions
From Vizgen, Inc.
Via Business Wire
Vizgen Kicks Off AGBT with Enhanced MERFISH Chemistry Updates and 2024 Product Roadmap Highlights
From Vizgen, Inc.
Via Business Wire
Vizgen and Scale Biosciences Unveil Strategic Partnership at AGBT
From Vizgen, Inc.
Via Business Wire
Vizgen Announces Series of Nature Studies Harnessing the Power of MERFISH Technology to Build the Most Comprehensive Cellular Map of the Adult Mouse Brain
From Vizgen, Inc.
Via Business Wire
Vizgen Provides Update on Litigation
From Vizgen, Inc.
Via Business Wire
Vizgen Issues Open Letter to Customers and Researchers on 10x Genomics June 1, 2023 Lawsuit Announcement in Europe
From Vizgen, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.